Chagas cardiomyopathy and ischemic stroke

References

• World Health Organization. Control of Chagas’ disease. 2nd report of the WHO Expert Committee. Geneva. WHO Technical Report Series. 905, (2002).
   Google Scholar
• Kirchoff LV. Trypanosoma species (American Trypanosomiasis, Chagas’ disease): biology of trypanosomes. In: Principles and Practice of Infectious Disease. Mandell GL, Bennett JE, Dolin R (Eds). Churchill Livingstone, NY, USA, 2442–2450 (1995).
   Google Scholar
• Lauria-Pires L, Teixeira ARL. Virulence and pathogenicity associated with diversity of Trypanosoma cruzi stocks and clones derived from Chagas’ disease patients. Am. J. Trop. Med. Hyg. 55, 304–310 (1996).
   PubMedGoogle Scholar
• Kirchoff LV. American trypanosomiasis (Chagas’ disease): a tropical disease now in the United States. N. Engl. J. Med. 329, 639–644 (1993).
   PubMed Web of Science ®Google Scholar
• Cegielsk JP, Durack DT. Trypanosomiasis. In: Infections of Central Nervous System. Scheld WM, Whitley RJ, Durack DT (Eds). Lippincott-Raven, PA, USA, 807–829 (1997).
   Google Scholar
• Chagas C. Nova tripanozomiase humana: estudos sob a morfologia e o ciclo evolutivo do Schizotrypanum cruzi n. Agente etiológico de nova entidade mórbida no homem. Mem. Inst. Oswaldo Cruz 1, 159–218 (1909).
   Google Scholar
• Bradley KK, Bergman DK, Woods JP, Crutcher JM, Kirchhoff LV. Prevalence of American trypanosomiasis (Chagas disease) among dogs in Oklahoma. J. Am. Vet. Med. Assoc. 217, 1853–1857 (2000).
   PubMedGoogle Scholar
• Leiby DA, Rentas FJ, Nelson KE et al. Evidence of Trypanosoma cruzi infection (Chagas’ disease) among patients undergoing cardiac surgery. Circulation 102, 2978–2982 (2000).
   PubMedGoogle Scholar
• DelBrutto OH, Carod-Artal FJ, Román GC, Sennanayake N. Stroke in the tropics. In: Tropical Neurology. American Academy of Neurology (Ed.) Lippincott Williams & Wilkins, PA, USA, 11–35 (2002).
   Google Scholar
• Rassi A Jr, Rassi A, Little WC. Chagas’ heart disease. Clin. Cardiol. 23, 883–889 (2000).
   PubMed Web of Science ®Google Scholar
• Ianni BM, Mady C, Arteaga E, Fernandes F. Doenças cardiovasculares observadas durante o seguimento de um grupo de pacientes na forma indeterminada da doença de Chagas. Arq. Bras. Cardiol. 71, 21–24 (1998).
   PubMedGoogle Scholar
• Umezawa ES, Stolf AMS, Corbett CEP, Shikanai-Yasuda MA. Chagas’ disease. Lancet 357, 797–799 (2001).
   PubMedGoogle Scholar
• Bestetti RB, Rossi MA. A rational approach for mortality risk stratification in Chagas’ heart disease. Int. J. Cardiol. 58, 199–209 (1997).
   PubMedGoogle Scholar
• Arteaga-Fernandez E, Baretto ACP, Ianni BM et al. Trombose cardíaca e embolia em pacientes falecidos de cardiopatia chagásica crónica. Arq. Bras. Cardiol. 52, 189–192 (1989).
   PubMedGoogle Scholar
• Torres FW, Acquatella H, Condado JA, Dinsmore R, Palacios IF. Coronary vascular reactivity is abnormal in patients with Chagas’ heart disease. Am. Heart. J. 129, 995–1001 (1995).
   PubMed Web of Science ®Google Scholar
• Barretto AC, Mady C, Ianni BM et al. Relação entre arritmia ventricular e função cardiaca na doença de Chagas. Arq. Bras. Cardiol. 64, 533–535 (1995).
   PubMedGoogle Scholar
• Oliveira JSM, Araujo RLC, Navarro MA, Muccillo G. Cardiac thrombosis and trhomboembolism in chronic Chagas’ heart disease. Am. J. Cardiol. 2, 147–151 (1983).
   Google Scholar
• Bestetti R. Stroke in a hospital-derived cohort of patients with chronic Chagas’ disease. Acta Cardiol. 55, 33–38 (2000).
   PubMed Web of Science ®Google Scholar
• NunesMdo C, Barbosa MM, Rocha MO. Peculiar aspects of cardiogenic embolism in patients with Chagas’ cardiomyopathy: a transthoracic and transesophageal echocardiographic study. J. Am. Soc. Echocardiogr. 18, 761–767 (2005).
   PubMedGoogle Scholar
• RodriguezSalas LA, Klein E, Acquatella H et al. Echocardiographic and clinical predictors of mortality in chronic Chagas’ disease. Echocardiography 15, 271–278 (1998).
   PubMedGoogle Scholar
• Patel AR, Lima C, Parro A, Arsenault M, Vannan MA, Pandian NG. Echocardiographic analysis of regional and global left ventricular shape in Chagas’ cardiomyopathy. Am. J. Cardiol. 82, 197–202 (1998).
   PubMedGoogle Scholar
• Albanesi-Filho FM, Gomes Filho JB. Thromboembolism in patients with apical lesion caused by chronic chagasic cardiopathy. Rev. Port. Cardiol. 10, 35–42 (1991).
   PubMedGoogle Scholar
• Viotti RJ, Vigliano C, Laucella S et al. Value of echocardiography for diagnosis and prognosis of chronic Chagas disease cardiomyopathy without heart failure. Heart 90, 655–660 (2004).
   Google Scholar
• Souza AP, Tang B, Tanowitz HB, Araujo-Jorge TC, Jelicks EL. Magnetic resonance imaging in experimental Chagas disease: a brief review of the utility of the method for monitoring right ventricular chamber dilatation. Parasitol. Res. 97, 87–90 (2005).
   PubMedGoogle Scholar
• Carod-Artal FJ, Vargas AP, Horan TA, Nunes LG. Chagasic cardiomyopathy is independently associated with ischemic stroke in Chagas disease. Stroke 36, 965–970 (2005).
   Google Scholar
• Oliveira-Filho J, Viana LC, Vieira-de-Melo RM et al. Chagas’ disease is an independent risk factor for stroke: baseline characteristics of a chagas disease cohort. Stroke 36, 2015–2017 (2005).
   PubMedGoogle Scholar
• Viotti R, Vigliano C, Locco B et al. Indicadores clínicos de progresión de la miocarditis chagásica crónica. Rev. Esp.Cardiol. 58, 1037–1044 (2005).
   PubMed Web of Science ®Google Scholar
• Macedo AM, Machado CR, Oliveira RP, Pena SD. Trypanosoma cruzi: genetic structure of populations and relevance of genetic variability to the pathogenesis of Chagas’ disease. Mem. Inst. Oswaldo Cruz 99, 1–12 (2004).
   PubMed Web of Science ®Google Scholar
• Tarleton RL. Parasite persistence in the etiology of Chagas disease. Int. J. Parasitol. 31, 550–554. (2001).
   PubMed Web of Science ®Google Scholar
• Britto C, Cardoso Ma, Vanni CM et al. Polymerase chain reaction detection of Trypanosoma cruzi in human blood samples as a tool for diagnosis and treatment evaluation. Parasitology 110, 241–247 (1995).
   PubMed Web of Science ®Google Scholar
• Elias FE, Vigliano CA, Laguens RP, Levin MJ, Berek C. Analysis of the presence of Trypanosoma cruzi in the heart tissue of three patients with chronic Chagas’ heart disease. Am. J. Trop. Med. Hyg. 68, 242–247 (2003).
   PubMed Web of Science ®Google Scholar
• Bocchi EA, Bellotti G, Mocelin AO et al. Heart transplantation for chronic Chagas’ heart disease. Ann. Thorac. Surg. 61, 1727–1733 (1996).
   PubMedGoogle Scholar
• Bestetti RB, Cury PM, Theodoropoulos TA, Villafanha D. Trypanosoma cruzi myocardial infection reactivation presenting as complete atrioventricular block in a Chagas’ heart transplant recipient. Cardiovasc. Pathol. 13, 323–326 (2004).
   PubMed Web of Science ®Google Scholar
• Zhang L, Tarleton RL. Parasite persistence correlates with disease severity and localization in chronic Chagas’ disease. J. Infect. Dis. 180, 480–486 (1999).
   PubMed Web of Science ®Google Scholar
• Schijman AG, Vigliano CA, Viotti RJ et al. Trypanosoma cruzi DNA in cardiac lesions of Argentinean patients with end stage chronic chagas heart disease. Am. J. Trop. Med. Hyg. 70, 210–220 (2004).
   PubMed Web of Science ®Google Scholar
• Ribeiro AL, Moraes RS, Ribeiro JP et al. Parasympathetic dysautonomia precedes left ventricular systolic dysfunction in Chagas disease. Am. Heart. J. 141, 260–265 (2001).
   PubMed Web of Science ®Google Scholar
• Bestetti RB, Coutinho-Netto J, Staibano L, Pinto LZ, Muccillo G, Oliveira JS. Peripheral and coronary sinus catecholamine levels in patients with severe congestive heart failure due to Chagas’ disease. Cardiology 86, 202–206 (1995).
   PubMedGoogle Scholar
• Baroldi G, Oliveira SJ, Silver MD. Sudden and unexpected death in clinically ‘silent’ Chagas’ disease. A hypothesis. Int. J. Cardiol. 58, 263–268 (1997).
   PubMedGoogle Scholar
• Davila DF, Rossell RO, Donis JH. Cardiac parasympathetic abnormalities: cause or consequence of Chagas heart disease. Parasitol. Today 5, 327–329 (1989).
   PubMedGoogle Scholar
• Davila DF, Donis JH, Torres A, Ferrer JA. A modified and unifying neurogenic hypothesis can explain the natural history of chronic Chagas heart disease. Int. J. Cardiol. 96, 191–195 (2002).
   Google Scholar
• Rossi MA, Ramos SG. Coronary microvascular abnormalities in Chagas’ disease. Am. Heart. J. 132, 207–210 (1996).
   PubMed Web of Science ®Google Scholar
• Rossi MA. Aortic endothelial cell changes in the acute septicemic phase of experimental Trypanosoma cruzi infection in rats: scanning and transmission electron microscopic study. Am. J. Trop. Med. Hyg. 57, 321–327 (1997).
   PubMed Web of Science ®Google Scholar
• Petkova SB, Huang H, Factor SM et al. The role of endothelin in the pathogenesis of Chagas’ disease. Int. J. Parasitol. 31, 499–511 (2001).
   PubMed Web of Science ®Google Scholar
• Marin Neto JA, Simoes MV, Ayres-Neto EM et al. Studies of the coronary circulation in Chagas’ heart disease. Rev. Paul. Med. 113, 826–834 (1995).
   Google Scholar
• Bestetti RB, Ariolli MT, do Carmo JL et al. Clinical characteristics of acute myocardial infarction in patients with Chagas’ disease. Int. J. Cardiol. 35, 371–376 (1992).
   PubMed Web of Science ®Google Scholar
• Kierszenbaum F. Chagas’ disease and the autoimmunity hypothesis. Clin. Microbiol. Rev. 12, 210–223 (1999).
   PubMed Web of Science ®Google Scholar
• Borda E, Pascual J, Cossio P, De la vega M, Arana R, Sterin-Borda L. A circulating IgG in Chagas’disease wchich binds to β-adrenoceptors of myocardium and modulates their activity. Clin. Exp. Immunol. 57, 679–686 (1984).
   PubMedGoogle Scholar
• Leon JS, Engman DM. Autoimmunity in Chagas heart disease. Int. J. Parasitol. 31, 555–561 (2001).
   PubMed Web of Science ®Google Scholar
• Girones N, Fresno M. Etiology of Chagas disease myocarditis: autoimmunity, parasite persistence, or both? Trends Parasitol. 19, 19–22 (2003).
   PubMed Web of Science ®Google Scholar
• Higuchi Mde L, Benvenuti LA, Martins Reis M, Metzger M. Pathophysiology of the heart in Chagas’ disease: current status and new developments. Cardiovasc. Res. 60, 96–107 (2003).
   PubMed Web of Science ®Google Scholar
• Frasch AC. Functional diversity in the trans-sialidase and mucin families in Trypanosoma cruzi. Parasitol. Today 16, 282–286 (2000).
   PubMedGoogle Scholar
• Pollevick GD, Di Noia JM, Salto ML et al. Trypanosoma cruzi surface mucins with exposed variant epitopes. J. Biol. Chem. 275, 27671–27680 (2000).
   PubMedGoogle Scholar
• Prata A. Clinical and epidemiological aspects of Chagas disease. Lancet Infect. Dis. 1, 92–100 (2001).
   PubMedGoogle Scholar
• Pitella JE, Meneguette C, Barbosa AJ. Histopathological and immunohistochemical study of the brain and heart in the chronic cardiac form of Chagas’ disease. Arq. Neuropsiquiatr. 51, 8–15 (1993).
   PubMedGoogle Scholar
• deQueiroz AC. Estudo anatomopatológico do encéfalo na forma crónica da doença de Chagas. Ver. Pat. Trop. 7, 134–145 (1978).
   Google Scholar
• Pitella JE. Ischemic cerebral changes in the chronic chagasic cardiopathy. Arq. Neuropsiquiatr. 42, 105–115 (1984).
   PubMedGoogle Scholar
• Aras R, da Matta JAM, Mota G, Gomes I, Melo A. Cerebral infarction in autopsies of chagasic patients with heart failure. Arq. Bras. Cardiol. 81, 414–416 (2003).
   PubMedGoogle Scholar
• Mady C, Cardoso RH, Barretto AC, da Luz PL, Bellotti G, Pileggi F. Survival and predictors of survival in patients with congestive heart failure due to Chagas’ cardiomyopathy. Circulation 90, 3098–3102 (1994).
   PubMed Web of Science ®Google Scholar
• Leon-Sarmiento FE, Mendoza E, Torres-Hillera M et al. Trypanosoma cruzi-associated cerebrovascular disease: a case-control study in Eastern Colombia. J. Neurol. Sciences 217, 61–64 (2004).
   PubMedGoogle Scholar
• Rey RC, Monteverde DA, Sicca RE. Cardiac sources of cerebral embolism. Arch. Neurol. 48, 359–60 (1991).
   PubMedGoogle Scholar
• CarodArtal FJ, Melo M, Vargas AP. Ictus cardioembólico en la enfermedad de Chagas. Rev. Neurol. 33, 311–315 (2001).
   PubMedGoogle Scholar
• CarodArtal FJ, Vargas AP, Melo M, Horan T. American Trypanosomiasis (Chagas’ disease): an unrecognized cause of stroke. J. Neurol. Neurosurg. Psychiatry 74, 516–518 (2003).
   PubMedGoogle Scholar
• Carod-Artal FJ, Vargas AP, Melo M, Fernandes da Silva TV. Síndrome de la oclusión rostral de la arteria basilar y enfermedad de Chagas. Rev. Neurol. 35, 337–341 (2002).
   PubMedGoogle Scholar
• Ho KKL, Anderson KM, Kannel WB, Grossman W, Levy D. Survival after the onset of congestive heart failure in the Framingham Heart Study subjects. Circulation 88, 107–115 (1993).
   PubMed Web of Science ®Google Scholar
• Carod-Artal FJ, Fernandes da Silva TV, Vilela Nunes S, Vargas AP, Horan TA. Thrombophilia is not a predictive factor of stroke in Chagas disease. Neurology 62(Suppl. 5), A240–A241 (2004).
   Google Scholar
• Zicker F, Smith PG, Almeida-Netto JC, Oliveira RM, Zicker EMS. Physical activity, opportunity for reinfection and sibling history of heart disease as risk factor for Chagas’ cardiopathy. Am. J. Trop. Med. Hyg. 43, 498–505 (1990).
   PubMed Web of Science ®Google Scholar
• Basquiera AL, Sembaj A, Aguerri AM et al. Risk progression to chronic Chagas cardiomyopathy: influence of male sex and of parasitaemia detected by polymerase chain reaction. Heart 89, 1186–1190 (2003).
   PubMed Web of Science ®Google Scholar
• Barrett MP, Burchmore RJ, Stich A et al. The trypanosomiases. Lancet 362, 1469–1480 (2003).
   Google Scholar
• Paulinoa M, Iribarnea F, Dubinb M, Aguilera-Moralesc S, Tapiad O, Stoppani AO. The chemotherapy of Chagas’ disease: an overview. Mini. Rev. Med. Chem. 5, 499–519 (2005).
   PubMedGoogle Scholar
• Dias JCP, Silveira AC, Schofield CJ. The impact of Chagas disease control in Latin America – a review. Mem. Inst. Oswaldo Cruz 97, 603–612 (2002).
   PubMed Web of Science ®Google Scholar
• Villar JC, Marin-Neto JA, Ebrahim S, Yusuf S. Trypanocidal therapy for chronic asymptomatic Trypanosoma cruzi infection: a systematic review. Cochrane Database Syst. Rev. 1, CD 003463, (2002).
   Google Scholar
• Reyes P, Vallejo M, Reyes P. Trypanocidal drugs for late stage, symptomatic Chagas disease (Trypanosoma cruzi infection): Cochrane Database Syst. Rev. 4, CD004102 (2005).
   Google Scholar
• Trabuco CC, Pereira de Jesus PA, Bacellar AS, Oliveira-Filho J. Successful thrombolysis in cardioembolic stroke from Chagas disease. Neurology 62, 170–171 (2005).
   Google Scholar
• Albers G, Amarenco P, Easton D et al. Antithrombotic and thrombolytic therapy for ischemic stroke. Chest 119(Suppl.), 300–320 (2001).
   PubMed Web of Science ®Google Scholar
• Hart RG, Halperin JL, Pearce LA et al. Lessons from the Stroke Prevention in Atrial Fibrillation trials. Ann. Intern. Med. 138, 831–838 (2003).
   PubMed Web of Science ®Google Scholar
• Mohr J, Thomson JLP, Lazar RM et al. For the Warfarin-Aspirin Recurrent Stroke Study Group. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N. Engl. J. Med. 345, 1444–1451 (2001).
   PubMed Web of Science ®Google Scholar
• The European/Australasian Stroke Prevention in Reversible Ischaemia Trial (ESPRIT) Study Group. Oral anticoagulation in patients after cerebral ischaemia of arterial origin and risk of intracranial hemorrhage. Stroke 34, E45–E46 (2003).
   Google Scholar